Answers are grounded in this paper and cite their sources.
The fat-signal fraction as a biomarker for multiple myeloma enables discrimination of symptomatic myeloma from asymptomatic myeloma. The fat-signal fraction offers superior sensitivity and specificity to BMPC% of biopsy specimens.
No takes yet. Share an insight, caveat, or question.
Takasu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: